drugset / Trial / NCT02183233

Efficacy and Safety of Eschscholtzia Californica in Treating Primary Insomnia

NCT02183233

Phase 3 Terminated 49 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this trial was to assess the efficacy and safety of Eschscholtzia Californica (EC) in treating patients having psycho-physiologic insomnia in a double-blind randomised placebo controlled trial during a 28-day treatment duration.

Timeline

Start
1998-01
Primary completion
1998-06
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Eschscholtzia Californica Unknown 1000 mg